Peer Review History

Original SubmissionMay 2, 2020

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Cheryl S. Rosenfeld, Editor

PONE-D-20-12899

The Influence of lockdown on the indications of cesarean delivery and newborn weights during the epidemic period of COVID-19 in Wuhan

PLOS ONE

Dear Dr. Zhao,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

This paper represents a resubmission of a previously submitted paper that was reviewed extensively. The authors were provided the opportunity to tone down their claims and ensure that throughout the paper it was clear that they are not examining how COVID-19 affects pregnancy outcomes or analyze such samples. They chose the former approach. The original reviewers have reviewed the revised paper and expressed conflicting recommendations. However, both agree that the work is not "blockbuster", but it may provide some comfort to pregnant women having to quarantine that it will not drastically affect their neonates. In reviewing the journal guidelines, it will allow for descriptive papers, such as this one. That being sad, it still needs to meet certain standards in terms of the English and previous and current reviewer concerns need to be addressed. It is recommended to have the revised manuscript proofed by an outside individual before it is resubmitted. Both reviewers have also provided helpful comments.

Please submit your revised manuscript by Jul 16 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Cheryl S. Rosenfeld, DVM, PhD

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.  We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

* In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This toned-down manuscript with a more accurate title is much improved. It might be helpful to have a reader fluent in English correct some of the minor grammatical and style errors, even though the narrative is easy to follow and is readily comprehensible. Overall, the paper sends a reassuring message to women confined to home during a pandemic.

Reviewer #2: This is a revised version of a manuscript in which the authors report various metrics related to late pregnancy, Caesarian deliveries and other aspects of pregnancy in the Wuhan, China region during the pandemic. The manuscript has been improved, and a large number of problems identified by the reviewers have been addressed.

There has been great interest in whether the infection of a pregnant mother would result in any changes in the fetus during late gestation or the infants after birth. Although the current study does not address this, the questions the authors do address have some value as well, but perhaps not enough to justify a publication in a broad and general interest journal like this. It seems like these types of data would be more appropriate for a specialty human journal that focused on Ob/Gyn, rather than a general interest journal like PLOS One.

There are still a number of problems with the English. It was recommended in the initial review that the authors consider using this type of service, or get some other editorial help from a native English speaker. Just a few of the types of problems that occur in the manuscript are listed below; this is by no means a complete list.

Line 114: you cannot start a sentence with a numeral in English.

Line 120: SCORES

Line 155: you cannot start a sentence with a numeral in English.

Line 197: change “pregnant women were trapped in their homes” to “pregnant women were confined to their homes”

Line 197-198: change “and it was not convenient for them to go out for taking a walk.” To “and their ability to exercise was limited.”

Tables 1, 3 and 4: The authors should review rules on significant digits. It does not seem correct to show the percentage values with two places to the right of the decimal. Would not whole percentages perhaps be better?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to Editor

Q1. This paper represents a resubmission of a previously submitted paper that was reviewed extensively. The authors were provided the opportunity to tone down their claims and ensure that throughout the paper it was clear that they are not examining how COVID-19 affects pregnancy outcomes or analyze such samples. They chose the former approach. The original reviewers have reviewed the revised paper and expressed conflicting recommendations. However, both agree that the work is not "blockbuster", but it may provide some comfort to pregnant women having to quarantine that it will not drastically affect their neonates. In reviewing the journal guidelines, it will allow for descriptive papers, such as this one. That being sad, it still needs to meet certain standards in terms of the English and previous and current reviewer concerns need to be addressed. It is recommended to have the revised manuscript proofed by an outside individual before it is resubmitted. Both reviewers have also provided helpful comments.

Response: Thanks for your comments. Following the reviewers’ comments, we have revised the manuscript carefully. In order to enhance the writing, a well-known outside professional editing institution has assisted us in improving the English writing of our manuscript with charges., which has substantially improved the quality of the paper.

Response to Comments of Reviewer 1

Comments: This toned-down manuscript with a more accurate title is much improved. It might be helpful to have a reader fluent in English correct some of the minor grammatical and style errors, even though the narrative is easy to follow and is readily comprehensible. Overall, the paper sends a reassuring message to women confined to home during a pandemic.

Respond: Thanks for your positive comments with respect to our previous revision. In this round of revision, a professional institution has helped us in improving the English writing.

Response to Comments of Reviewer 2

Q1:There are still a number of problems with the English. It was recommended in the initial review that the authors consider using this type of service, or get some other editorial help from a native English speaker. Just a few of the types of problems that occur in the manuscript are listed below; this is by no means a complete list.

Line 114: you cannot start a sentence with a numeral in English.

Line 120: SCORES

Line 155: you cannot start a sentence with a numeral in English.

Line 197: change “pregnant women were trapped in their homes” to “pregnant women were confined to their homes”

Line 197-198: change “and it was not convenient for them to go out for taking a walk.” To “and their ability to exercise was limited.”

Response: Thanks for your comments. In the revised manuscript, we have corrected all the mistakes you pointed out. In addition, a well-known professional institution has helped us in improving the overall English writing.

Q2. Tables 1, 3 and 4: The authors should review rules on significant digits. It does not seem correct to show the percentage values with two places to the right of the decimal. Would not whole percentages perhaps be better?

Respond:According to your comments, we have reviewed the papers with respect to retrospective study published on PLOS ONE, which have been listed below. We decide the follow their rules on significant digits and also the percentage values. The corresponding tables Tables 1, 3 and 4 have been revised carefully.

Chu S, Chen Q, Chen Y, et al. Cesarean section without medical indication and risk of childhood asthma, and attenuation by breastfeeding[J]. PLoS One, 2017, 12(9): e0184920.

Decision Letter - Cheryl S. Rosenfeld, Editor

Impact of Wuhan lockdown on the indications of cesarean delivery and newborn weights during the epidemic period of COVID-19

PONE-D-20-12899R1

Dear Dr. Zhao,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Cheryl S. Rosenfeld, DVM, PhD

Section Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper is now suitable for publication. The written English is much improved and the the conclusions suitably muted.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Formally Accepted
Acceptance Letter - Cheryl S. Rosenfeld, Editor

PONE-D-20-12899R1

Impact of Wuhan lockdown on the indications of cesarean delivery and newborn weights during the epidemic period of COVID-19

Dear Dr. Zhao:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Cheryl S. Rosenfeld

Section Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .